NCT00386555: A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. |
|
|
| Withdrawn | 2 | 0 | US | docetaxel, CP-868,596 + docetaxel, AG-013736 + docetaxel, CP-868,596 + AG-013736 + docetaxel | Arog Pharmaceuticals, Inc. | Carcinoma, Non-Small-Cell Lung | | | | |
